Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 92.86% to -5 cents per share on November 11

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q3'26

Est.

$-0.06

Q2'26

Beat

by $0.21

Q1'26

Beat

by $0.17

Q4'25

Missed

by $5.31

Q3'25

Missed

by $6.02

The last earnings report on August 06 showed earnings per share of -83 cents, beating the estimate of -104 cents. With 474.90K shares outstanding, the current market capitalization sits at 411.00M.

View a ticker or compare two or three

ARCT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ARCT